Cover Image

Infliximab as rescue therapy in refractory Kawasaki disease

Saved in:

Bibliographic Details
Main Authors:	Moisés Rodríguez-González (Author), Miguel A Matamala-Morillo (Author), Antonio Segado-Arenas (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2014-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EFFICACY OF INFLIXIMAB IN THERAPY OF REFRACTORY JUVENILE RHEUMATOID ARTHRITIS (JRA)EFFICACY OF INFLIXIMAB IN THERAPY OF REFRACTORY JUVENILE RHEUMATOID ARTHRITIS (JRA)
by: E.I. Alexeeva, et al.
Published: (2006)

EFFICACY OF INFLIXIMAB IN THERAPY OF REFRACTORY JUVENILE RHEUMATOID ARTHRITIS (JRA)EFFICACY OF INFLIXIMAB IN THERAPY OF REFRACTORY JUVENILE RHEUMATOID ARTHRITIS (JRA)
by: E.I. Alexeeva, et al.
Published: (2006)

Recurrent refractory Kawasaki disease
by: Imundo L, et al.
Published: (2011)

INFLIXIMAB IN TREATMENT OF REFRACTORY JUVENILE ARTHRITIS
by: I.P. Nikishina, et al.
Published: (2010)

INFLIXIMAB IN TREATMENT OF REFRACTORY JUVENILE ARTHRITIS
by: I.P. Nikishina, et al.
Published: (2010)

Intra-articular therapy with infliximab in psoriatic arthritis: efficacy and safety in refractory monoarthritis
by: A. Minosi, et al.
Published: (2011)

Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience
by: Miguel Cordero-Coma, et al.
Published: (2014)

Cyclosporine for refractory Kawasaki disease with psoriasiform eruption
by: Mara Leyendecker, BS, et al.
Published: (2021)

Refractory Kawasaki disease: diagnostic and management challenges
by: Duignan S, et al.
Published: (2019)

Sudden Cardiac Death as the First Clinical Manifestation in Infants With Asymptomatic Ventricular Pre-excitation: Two Case Reports and Review of the Literature
by: Moises Rodriguez-Gonzalez, et al.
Published: (2019)

Canakinumab as rescue therapy in familial Mediterranean fever refractory to conventional treatment
by: Alpa M, et al.
Published: (2015)

Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review
by: Courtney B. Crayne, et al.
Published: (2019)

Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy
by: M. Gattinara, et al.
Published: (2011)

Intravenous immunoglobulin for the rescue in refractory cutaneous lupus
by: Harpreet Singh, et al.
Published: (2020)

Successful treatment of refractory checkpoint inhibitor‐induced hepatitis with quadruple therapy including extracorporeal photopheresis and infliximab
by: Inga Hansen, et al.
Published: (2024)

Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report
by: Klein Nigel J, et al.
Published: (2009)

Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms
by: Olha Halyabar, et al.
Published: (2021)

Clinical outcome of patients with refractory Kawasaki disease based on treatment modalities
by: Hyun Jung Kim, et al.
Published: (2016)

Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin's Disease
by: Florian Lüke, et al.
Published: (2021)

Resolution of Giant Coronary Aneurisms in a Child With Refractory Kawasaki Disease Treated With Anakinra
by: Alessandro Gambacorta, et al.
Published: (2020)

Metastatic Crohn's disease despite infliximab therapy
by: Sara Campos, et al.
Published: (2017)

Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease
by: Han Chan, et al.
Published: (2019)

The Efficacy and Safety of Infliximab in Refractory Noninfectious Uveitis: A Meta-Analysis of Observational Studies
by: Anji Xiong, et al.
Published: (2021)

Individualized infliximab therapy: pharmacokinetic monitoring
by: Eugènia Santacana-Juncosa, et al.
Published: (2015)

Incomplete Refractory Kawasaki Disease in an Infant-A Case Report and a Review of the Literature
by: Cristina O. Mărginean, et al.
Published: (2018)

Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis
by: Virginia Miraldi Utz, et al.
Published: (2019)

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
by: Neda Shahriari, MD, et al.
Published: (2023)

The use of intravenous immunoglobulin as a rescue therapy for refractory parainfectious leprosy-related neuritis: a case series
by: João Guilherme Pessôa Léo, et al.
Published: (2024)

Prediction of unresponsiveness to second intravenous immunoglobulin treatment in patients with Kawasaki disease refractory to initial treatment
by: Euri Seo, et al.
Published: (2016)

Under-Recognized Macrophage Activation Syndrome in Refractory Kawasaki Disease: A Wolf in Sheep's Clothing
by: Sangwon Rhee, et al.
Published: (2022)

Early intestinal obstruction after infliximab therapy in Crohn's disease
by: Mitsuro Chiba, et al.
Published: (2019)

ECMO as an effective rescue therapeutic for fulminant myocarditis complicated with refractory cardiac arrest
by: Li YT, et al.
Published: (2017)

Infliximab in inflammatory bowel disease
by: Konstantinos Papamichael, et al.
Published: (2019)

CONTINUOUS INFLIXIMAB THERAPY FOR A 14-YEARS-OLD GIRL WITH CROHN DISEASE
by: E.N. Fedulova, et al.
Published: (2009)

CONTINUOUS INFLIXIMAB THERAPY FOR A 14-YEARS-OLD GIRL WITH CROHN DISEASE
by: E.N. Fedulova, et al.
Published: (2009)

Loss of Response to Long-Term Infliximab Therapy in Children with Crohn's Disease
by: George Alex, et al.
Published: (2013)

Infliximab
by: İlgen Ertam Sağduyu
Published: (2022)

Infliximab therapy for Netherton syndrome: A case report
by: Ãngela Roda, MD, et al.
Published: (2017)

Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection - Reply
by: M. Galeazzi
Published: (2003)

Switch from Infliximab to Infliximab-dyyb for Rheumatology Indications
by: Alexi Spoto, et al.
Published: (2021)